{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:55:30Z","timestamp":1791230130514,"version":"4.1.0"},"reference-count":129,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:00:00Z","timestamp":1642896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["JRF"],"award-info":[{"award-number":["JRF"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12035-021-02683-5","type":"journal-article","created":{"date-parts":[[2022,1,23]],"date-time":"2022-01-23T00:04:21Z","timestamp":1642896261000},"page":"2288-2304","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases"],"prefix":"10.1007","volume":"59","author":[{"given":"Subhashini","family":"Brahadeeswaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narmadhaa","family":"Sivagurunathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6637-369X","authenticated-orcid":false,"given":"Latchoumycandane","family":"Calivarathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,23]]},"reference":[{"issue":"15\u201316","key":"2683_CR1","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1002\/pmic.201100668","volume":"12","author":"P Ottis","year":"2012","unstructured":"Ottis P, Koppe K, Onisko B, Dynin I, Arzberger T, Kretzschmar H, Requena JR, Silva CJ et al (2012) Human and rat brain lipofuscin proteome. Proteomics 12(15\u201316):2445\u20132454. https:\/\/doi.org\/10.1002\/pmic.201100668","journal-title":"Proteomics"},{"key":"2683_CR2","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.neurobiolaging.2015.09.019","volume":"37","author":"DV Clewett","year":"2016","unstructured":"Clewett DV, Lee TH, Greening S, Ponzio A, Margalit E, Mather M (2016) Neuromelanin marks the spot: identifying a locus coeruleus biomarker of cognitive reserve in healthy aging. Neurobiol Aging 37:117\u2013126. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.09.019","journal-title":"Neurobiol Aging"},{"key":"2683_CR3","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.smim.2018.09.001","volume":"40","author":"E Latz","year":"2018","unstructured":"Latz E, Duewell P (2018) NLRP3 inflammasome activation in inflammaging. Semin Immunol 40:61\u201373. https:\/\/doi.org\/10.1016\/j.smim.2018.09.001","journal-title":"Semin Immunol"},{"issue":"3","key":"2683_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.arr.2010.11.002","volume":"10","author":"T Singh","year":"2011","unstructured":"Singh T, Newman AB (2011) Inflammatory markers in population studies of aging. Ageing Res Rev 10(3):319\u2013329. https:\/\/doi.org\/10.1016\/j.arr.2010.11.002","journal-title":"Ageing Res Rev"},{"issue":"10","key":"2683_CR5","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41574-018-0059-4","volume":"14","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A (2018) Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol 14(10):576\u2013590. https:\/\/doi.org\/10.1038\/s41574-018-0059-4","journal-title":"Nat Rev Endocrinol"},{"key":"2683_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.smim.2018.10.008","volume":"40","author":"C Franceschi","year":"2018","unstructured":"Franceschi C, Zaikin A, Gordleeva S, Ivanchenko M, Bonifazi F, Storci G, Bonafe M (2018) Inflammaging 2018: an update and a model. Semin Immunol 40:1\u20135. https:\/\/doi.org\/10.1016\/j.smim.2018.10.008","journal-title":"Semin Immunol"},{"key":"2683_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2017.10.379","volume":"115","author":"V Calabrese","year":"2018","unstructured":"Calabrese V, Santoro A, Monti D, Crupi R, Di Paola R, Latteri S, Cuzzocrea S, Zappia M et al (2018) Aging and Parkinson\u2019s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radical Biol Med 115:80\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.10.379","journal-title":"Free Radical Biol Med"},{"key":"2683_CR8","doi-asserted-by":"publisher","first-page":"111467","DOI":"10.1016\/j.mad.2021.111467","volume":"195","author":"S Cicolari","year":"2021","unstructured":"Cicolari S, Catapano AL, Magni P (2021) Inflammaging and neurodegenerative diseases: role of NLRP3 inflammasome activation in brain atherosclerotic vascular disease. Mech Ageing Dev 195:111467. https:\/\/doi.org\/10.1016\/j.mad.2021.111467","journal-title":"Mech Ageing Dev"},{"key":"2683_CR9","doi-asserted-by":"publisher","unstructured":"Dugger BN, Dickson DW (2017) Pathology of neurodegenerative diseases. Cold Spring Harbor perspectives in biology 9(7):a028035.  https:\/\/doi.org\/10.1101\/cshperspect.a028035","DOI":"10.1101\/cshperspect.a028035"},{"issue":"10","key":"2683_CR10","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/s41583-018-0055-7","volume":"19","author":"MT Heneka","year":"2018","unstructured":"Heneka MT, McManus RM, Latz E (2018) Inflammasome signalling in brain function and neurodegenerative disease. Nat Rev Neurosci 19(10):610\u2013621. https:\/\/doi.org\/10.1038\/s41583-018-0055-7","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"2683_CR11","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/JVI.02667-12","volume":"87","author":"M Kumar","year":"2013","unstructured":"Kumar M, Roe K, Orillo B, Muruve DA, Nerurkar VR, Gale M Jr, Verma S (2013) Inflammasome adaptor protein apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitis. J Virol 87(7):3655\u20133667. https:\/\/doi.org\/10.1128\/JVI.02667-12","journal-title":"J Virol"},{"issue":"11","key":"2683_CR12","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1073\/pnas.0707370105","volume":"105","author":"SL Fink","year":"2008","unstructured":"Fink SL, Bergsbaken T, Cookson BT (2008) Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms. Proc Natl Acad Sci U S A 105(11):4312\u20134317. https:\/\/doi.org\/10.1073\/pnas.0707370105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2683_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1615\/critrevimmunol.v30.i5.50","volume":"30","author":"S Khare","year":"2010","unstructured":"Khare S, Luc N, Dorfleutner A, Stehlik C (2010) Inflammasomes and their activation. Crit Rev Immunol 30(5):463\u2013487. https:\/\/doi.org\/10.1615\/critrevimmunol.v30.i5.50","journal-title":"Crit Rev Immunol"},{"key":"2683_CR14","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3389\/fphar.2019.01008","volume":"10","author":"L Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Andrade V, Navarrete LP, Pastor MG, Ramos-Escobar N (2019) Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol 10:1008. https:\/\/doi.org\/10.3389\/fphar.2019.01008","journal-title":"Front Pharmacol"},{"issue":"2","key":"2683_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.immuni.2008.07.009","volume":"29","author":"M Yoneyama","year":"2008","unstructured":"Yoneyama M, Fujita T (2008) Structural mechanism of RNA recognition by the RIG-I-like receptors. Immunity 29(2):178\u2013181. https:\/\/doi.org\/10.1016\/j.immuni.2008.07.009","journal-title":"Immunity"},{"issue":"3","key":"2683_CR16","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cyto.2008.07.013","volume":"43","author":"S Benko","year":"2008","unstructured":"Benko S, Philpott DJ, Girardin SE (2008) The microbial and danger signals that activate Nod-like receptors. Cytokine 43(3):368\u2013373. https:\/\/doi.org\/10.1016\/j.cyto.2008.07.013","journal-title":"Cytokine"},{"issue":"7237","key":"2683_CR17","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/nature07725","volume":"458","author":"V Hornung","year":"2009","unstructured":"Hornung V, Ablasser A, Charrel-Dennis M, Bauernfeind F, Horvath G, Caffrey DR, Latz E, Fitzgerald KA (2009) AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458(7237):514\u2013518. https:\/\/doi.org\/10.1038\/nature07725","journal-title":"Nature"},{"issue":"6","key":"2683_CR18","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397\u2013411. https:\/\/doi.org\/10.1038\/nri3452","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"2683_CR19","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1111\/cns.13262","volume":"25","author":"MY Hu","year":"2019","unstructured":"Hu MY, Lin YY, Zhang BJ, Lu DL, Lu ZQ, Cai W (2019) Update of inflammasome activation in microglia\/macrophage in aging and aging-related disease. CNS Neurosci Ther 25(12):1299\u20131307. https:\/\/doi.org\/10.1111\/cns.13262","journal-title":"CNS Neurosci Ther"},{"key":"2683_CR20","doi-asserted-by":"publisher","unstructured":"Mammana S, Fagone P, Cavalli E, Basile MS, Petralia MC, Nicoletti F, Bramanti P, Mazzon E (2018) The role of macrophages in neuroinflammatory and neurodegenerative pathways of Alzheimer's disease, amyotrophic lateral sclerosis, and multiple sclerosis: pathogenetic cellular effectors and potential therapeutic targets. Int J Mol Sci 19(3): 831. https:\/\/doi.org\/10.3390\/ijms19030831","DOI":"10.3390\/ijms19030831"},{"issue":"1","key":"2683_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0361-9230(94)90189-9","volume":"34","author":"EJ Davis","year":"1994","unstructured":"Davis EJ, Foster TD, Thomas WE (1994) Cellular forms and functions of brain microglia. Brain Res Bull 34(1):73\u201378. https:\/\/doi.org\/10.1016\/0361-9230(94)90189-9","journal-title":"Brain Res Bull"},{"key":"2683_CR22","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/978-3-319-89390-7_13","volume":"108","author":"F Marin-Aguilar","year":"2018","unstructured":"Marin-Aguilar F, Ruiz-Cabello J, Cordero MD (2018) Aging and the inflammasomes. Exp Suppl 108:303\u2013320. https:\/\/doi.org\/10.1007\/978-3-319-89390-7_13","journal-title":"Exp Suppl"},{"key":"2683_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12950-018-0198-3","volume":"15","author":"NH Mejias","year":"2018","unstructured":"Mejias NH, Martinez CC, Stephens ME, de Rivero Vaccari JP (2018) Contribution of the inflammasome to inflammaging. J Inflamm (Lond) 15:23. https:\/\/doi.org\/10.1186\/s12950-018-0198-3","journal-title":"J Inflamm (Lond)"},{"issue":"4","key":"2683_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.cmet.2013.09.010","volume":"18","author":"YH Youm","year":"2013","unstructured":"Youm YH, Grant RW, McCabe LR, Albarado DC, Nguyen KY, Ravussin A, Pistell P, Newman S et al (2013) Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging. Cell Metab 18(4):519\u2013532. https:\/\/doi.org\/10.1016\/j.cmet.2013.09.010","journal-title":"Cell Metab"},{"key":"2683_CR25","doi-asserted-by":"publisher","unstructured":"Sebastian-Valverde M, Pasinetti GM (2020) The NLRP3 inflammasome as a critical actor in the inflammaging process. Cells 9(6):1552.  https:\/\/doi.org\/10.3390\/cells9061552","DOI":"10.3390\/cells9061552"},{"key":"2683_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-med-050715-104343","volume":"69","author":"LI Labzin","year":"2018","unstructured":"Labzin LI, Heneka MT, Latz E (2018) Innate immunity and neurodegeneration. Annu Rev Med 69:437\u2013449. https:\/\/doi.org\/10.1146\/annurev-med-050715-104343","journal-title":"Annu Rev Med"},{"key":"2683_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/msb.2013.15","volume":"9","author":"D Furman","year":"2013","unstructured":"Furman D, Jojic V, Kidd B, Shen-Orr S, Price J, Jarrell J, Tse T, Huang H et al (2013) Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol 9:659. https:\/\/doi.org\/10.1038\/msb.2013.15","journal-title":"Mol Syst Biol"},{"issue":"2","key":"2683_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.autrev.2011.09.005","volume":"11","author":"F Sardi","year":"2011","unstructured":"Sardi F, Fassina L, Venturini L, Inguscio M, Guerriero F, Rolfo E, Ricevuti G (2011) Alzheimer\u2019s disease, autoimmunity and inflammation. The good, the bad and the ugly. Autoimmun Rev 11(2):149\u2013153. https:\/\/doi.org\/10.1016\/j.autrev.2011.09.005","journal-title":"Autoimmun Rev"},{"issue":"7","key":"2683_CR29","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.autrev.2010.12.006","volume":"10","author":"R Scrivo","year":"2011","unstructured":"Scrivo R, Vasile M, Bartosiewicz I, Valesini G (2011) Inflammation as \u201ccommon soil\u201d of the multifactorial diseases. Autoimmun Rev 10(7):369\u2013374. https:\/\/doi.org\/10.1016\/j.autrev.2010.12.006","journal-title":"Autoimmun Rev"},{"issue":"10","key":"2683_CR30","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3978\/j.issn.2305-5839.2015.03.49","volume":"3","author":"WY Wang","year":"2015","unstructured":"Wang WY, Tan MS, Yu JT, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer\u2019s disease. Ann Transl Med 3(10):136. https:\/\/doi.org\/10.3978\/j.issn.2305-5839.2015.03.49","journal-title":"Ann Transl Med"},{"issue":"1","key":"2683_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/s0006-8993(00)02883-3","volume":"885","author":"KK Tha","year":"2000","unstructured":"Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y, Nomura Y (2000) Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence accelerated mouse (SAM) P8. Brain Res 885(1):25\u201331. https:\/\/doi.org\/10.1016\/s0006-8993(00)02883-3","journal-title":"Brain Res"},{"key":"2683_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev-cellbio-101011-155745","volume":"28","author":"M Lamkanfi","year":"2012","unstructured":"Lamkanfi M, Dixit VM (2012) Inflammasomes and their roles in health and disease. Annu Rev Cell Dev Biol 28:137\u2013161. https:\/\/doi.org\/10.1146\/annurev-cellbio-101011-155745","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"2","key":"2683_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/glia.10161","volume":"40","author":"UK Hanisch","year":"2002","unstructured":"Hanisch UK (2002) Microglia as a source and target of cytokines. Glia 40(2):140\u2013155. https:\/\/doi.org\/10.1002\/glia.10161","journal-title":"Glia"},{"issue":"5","key":"2683_CR34","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1084\/jem.20150237","volume":"214","author":"L Freeman","year":"2017","unstructured":"Freeman L, Guo H, David CN, Brickey WJ, Jha S, Ting JP (2017) NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes. J Exp Med 214(5):1351\u20131370. https:\/\/doi.org\/10.1084\/jem.20150237","journal-title":"J Exp Med"},{"issue":"1","key":"2683_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13195-015-0125-2","volume":"7","author":"P Theriault","year":"2015","unstructured":"Theriault P, ElAli A, Rivest S (2015) The dynamics of monocytes and microglia in Alzheimer\u2019s disease. Alzheimers Res Ther 7(1):41. https:\/\/doi.org\/10.1186\/s13195-015-0125-2","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2683_CR36","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s12035-020-02198-5","volume":"58","author":"Z Ou","year":"2021","unstructured":"Ou Z, Zhou Y, Wang L, Xue L, Zheng J, Chen L, Tong Q (2021) NLRP3 inflammasome inhibition prevents alpha-synuclein pathology by relieving autophagy dysfunction in chronic MPTP-treated NLRP3 knockout mice. Mol Neurobiol 58(4):1303\u20131311. https:\/\/doi.org\/10.1007\/s12035-020-02198-5","journal-title":"Mol Neurobiol"},{"issue":"14","key":"2683_CR37","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1111\/jcmm.15439","volume":"24","author":"C Han","year":"2020","unstructured":"Han C, Yang Y, Guan Q, Zhang X, Shen H, Sheng Y, Wang J, Zhou X, Li W, Guo L, Jiao Q (2020) New mechanism of nerve injury in Alzheimer\u2019s disease: beta-amyloid-induced neuronal pyroptosis. J Cell Mol Med 24(14):8078\u20138090. https:\/\/doi.org\/10.1111\/jcmm.15439","journal-title":"J Cell Mol Med"},{"issue":"5","key":"2683_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1097\/00005072-199009000-00010","volume":"49","author":"R Lindenberg","year":"1990","unstructured":"Lindenberg R (1990) Neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol 49(5):535\u2013537. https:\/\/doi.org\/10.1097\/00005072-199009000-00010","journal-title":"J Neuropathol Exp Neurol"},{"key":"2683_CR39","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG (2020) Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis 12:1179573520907397. https:\/\/doi.org\/10.1177\/1179573520907397","journal-title":"J Cent Nerv Syst Dis"},{"issue":"5","key":"2683_CR40","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nri1843","volume":"6","author":"HL Weiner","year":"2006","unstructured":"Weiner HL, Frenkel D (2006) Immunology and immunotherapy of Alzheimer\u2019s disease. Nat Rev Immunol 6(5):404\u2013416. https:\/\/doi.org\/10.1038\/nri1843","journal-title":"Nat Rev Immunol"},{"issue":"5556","key":"2683_CR41","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1126\/science.1067484","volume":"295","author":"MR Chapman","year":"2002","unstructured":"Chapman MR, Robinson LS, Pinkner JS, Roth R, Heuser J, Hammar M, Normark S, Hultgren SJ (2002) Role of Escherichia coli curli operons in directing amyloid fiber formation. Science 295(5556):851\u2013855. https:\/\/doi.org\/10.1126\/science.1067484","journal-title":"Science"},{"issue":"8","key":"2683_CR42","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/ni.1636","volume":"9","author":"A Halle","year":"2008","unstructured":"Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9(8):857\u2013865. https:\/\/doi.org\/10.1038\/ni.1636","journal-title":"Nat Immunol"},{"issue":"1","key":"2683_CR43","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s12017-013-8274-6","volume":"16","author":"N Murphy","year":"2014","unstructured":"Murphy N, Grehan B, Lynch MA (2014) Glial uptake of amyloid beta induces NLRP3 inflammasome formation via cathepsin-dependent degradation of NLRP10. NeuroMol Med 16(1):205\u2013215. https:\/\/doi.org\/10.1007\/s12017-013-8274-6","journal-title":"NeuroMol Med"},{"key":"2683_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-016-0088-1","volume":"11","author":"M Saresella","year":"2016","unstructured":"Saresella M, La Rosa F, Piancone F, Zoppis M, Marventano I, Calabrese E, Rainone V, Nemni R et al (2016) The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer\u2019s disease. Mol Neurodegener 11:23. https:\/\/doi.org\/10.1186\/s13024-016-0088-1","journal-title":"Mol Neurodegener"},{"issue":"4","key":"2683_CR45","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/sj.mp.4001809","volume":"11","author":"AR Simard","year":"2006","unstructured":"Simard AR, Rivest S (2006) Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer\u2019s disease. Mol Psychiatry 11(4):327\u2013335. https:\/\/doi.org\/10.1038\/sj.mp.4001809","journal-title":"Mol Psychiatry"},{"issue":"3","key":"2683_CR46","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/0165-5728(89)90115-x","volume":"24","author":"S Itagaki","year":"1989","unstructured":"Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D (1989) Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24(3):173\u2013182. https:\/\/doi.org\/10.1016\/0165-5728(89)90115-x","journal-title":"J Neuroimmunol"},{"issue":"7434","key":"2683_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nature11729","volume":"493","author":"MT Heneka","year":"2013","unstructured":"Heneka MT, Kummer MP, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A, Griep A, Axt D et al (2013) NLRP3 is activated in Alzheimer\u2019s disease and contributes to pathology in APP\/PS1 mice. Nature 493(7434):674\u2013678. https:\/\/doi.org\/10.1038\/nature11729","journal-title":"Nature"},{"issue":"1","key":"2683_CR48","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41380-018-0108-3","volume":"24","author":"E Martin","year":"2019","unstructured":"Martin E, Amar M, Dalle C, Youssef I, Boucher C, Le Duigou C, Bruckner M, Prigent A et al (2019) New role of P2X7 receptor in an Alzheimer\u2019s disease mouse model. Mol Psychiatry 24(1):108\u2013125. https:\/\/doi.org\/10.1038\/s41380-018-0108-3","journal-title":"Mol Psychiatry"},{"issue":"2","key":"2683_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/revneuro.2007.18.2.137","volume":"18","author":"C Gemma","year":"2007","unstructured":"Gemma C, Bickford PC (2007) Interleukin-1beta and caspase-1: players in the regulation of age-related cognitive dysfunction. Rev Neurosci 18(2):137\u2013148. https:\/\/doi.org\/10.1515\/revneuro.2007.18.2.137","journal-title":"Rev Neurosci"},{"key":"2683_CR50","doi-asserted-by":"publisher","first-page":"239821282097980","DOI":"10.1177\/2398212820979802","volume":"4","author":"JM Bourgognon","year":"2020","unstructured":"Bourgognon JM, Cavanagh J (2020) The role of cytokines in modulating learning and memory and brain plasticity. Brain Neurosci Adv 4:2398212820979802. https:\/\/doi.org\/10.1177\/2398212820979802","journal-title":"Brain Neurosci Adv"},{"issue":"2","key":"2683_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1017\/S0007114511002868","volume":"107","author":"Z Wang","year":"2012","unstructured":"Wang Z, Liu D, Wang F, Liu S, Zhao S, Ling EA, Hao A (2012) Saturated fatty acids activate microglia via Toll-like receptor 4\/NF-kappaB signalling. Br J Nutr 107(2):229\u2013241. https:\/\/doi.org\/10.1017\/S0007114511002868","journal-title":"Br J Nutr"},{"issue":"6","key":"2683_CR52","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1111\/j.1471-4159.2012.07660.x","volume":"120","author":"S Gupta","year":"2012","unstructured":"Gupta S, Knight AG, Gupta S, Keller JN, Bruce-Keller AJ (2012) Saturated long-chain fatty acids activate inflammatory signaling in astrocytes. J Neurochem 120(6):1060\u20131071. https:\/\/doi.org\/10.1111\/j.1471-4159.2012.07660.x","journal-title":"J Neurochem"},{"issue":"2","key":"2683_CR53","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.neurobiolaging.2013.08.016","volume":"35","author":"L Liu","year":"2014","unstructured":"Liu L, Chan C (2014) IPAF inflammasome is involved in interleukin-1beta production from astrocytes, induced by palmitate; implications for Alzheimer\u2019s Disease. Neurobiol Aging 35(2):309\u2013321. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.08.016","journal-title":"Neurobiol Aging"},{"key":"2683_CR54","doi-asserted-by":"publisher","first-page":"626128","DOI":"10.3389\/fncel.2021.626128","volume":"15","author":"NZ Gcwensa","year":"2021","unstructured":"Gcwensa NZ, Russell DL, Cowell RM, Volpicelli-Daley LA (2021) Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s disease. Front Cell Neurosci 15:626128. https:\/\/doi.org\/10.3389\/fncel.2021.626128","journal-title":"Front Cell Neurosci"},{"key":"2683_CR55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383. https:\/\/doi.org\/10.1016\/j.expneurol.2012.01.011","journal-title":"Exp Neurol"},{"issue":"1","key":"2683_CR56","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/toxsci\/kfy219","volume":"166","author":"FL Anderson","year":"2018","unstructured":"Anderson FL, Coffey MM, Berwin BL, Havrda MC (2018) Inflammasomes: an emerging mechanism translating environmental toxicant exposure into neuroinflammation in Parkinson\u2019s disease. Toxicol Sci 166(1):3\u201315. https:\/\/doi.org\/10.1093\/toxsci\/kfy219","journal-title":"Toxicol Sci"},{"key":"2683_CR57","doi-asserted-by":"publisher","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11(6):e10248. https:\/\/doi.org\/10.15252\/emmm.201810248","DOI":"10.15252\/emmm.201810248"},{"issue":"8","key":"2683_CR58","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/sj.bjp.0707167","volume":"150","author":"PS Whitton","year":"2007","unstructured":"Whitton PS (2007) Inflammation as a causative factor in the aetiology of Parkinson\u2019s disease. Br J Pharmacol 150(8):963\u2013976. https:\/\/doi.org\/10.1038\/sj.bjp.0707167","journal-title":"Br J Pharmacol"},{"key":"2683_CR59","doi-asserted-by":"publisher","unstructured":"Drouin-Ouellet J, St-Amour I, Saint-Pierre M, Lamontagne-Proulx J, Kriz J, Barker RA, Cicchetti F (2014) Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease. Int J Neuropsychopharmacol 18(6):pyu103. https:\/\/doi.org\/10.1093\/ijnp\/pyu103","DOI":"10.1093\/ijnp\/pyu103"},{"key":"2683_CR60","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, McGavern DB (2014) Microglia development and function. Annu Rev Immunol 32:367\u2013402. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120240","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"2683_CR61","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbi.2009.12.001","volume":"24","author":"D Litteljohn","year":"2010","unstructured":"Litteljohn D, Cummings A, Brennan A, Gill A, Chunduri S, Anisman H, Hayley S (2010) Interferon-gamma deficiency modifies the effects of a chronic stressor in mice: implications for psychological pathology. Brain Behav Immun 24(3):462\u2013473. https:\/\/doi.org\/10.1016\/j.bbi.2009.12.001","journal-title":"Brain Behav Immun"},{"issue":"6","key":"2683_CR62","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1006\/mcne.2000.0914","volume":"16","author":"C Knott","year":"2000","unstructured":"Knott C, Stern G, Wilkin GP (2000) Inflammatory regulators in Parkinson\u2019s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci 16(6):724\u2013739. https:\/\/doi.org\/10.1006\/mcne.2000.0914","journal-title":"Mol Cell Neurosci"},{"issue":"8","key":"2683_CR63","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/wnl.38.8.1285","volume":"38","author":"PL McGeer","year":"1988","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38(8):1285\u20131291. https:\/\/doi.org\/10.1212\/wnl.38.8.1285","journal-title":"Neurology"},{"issue":"4","key":"2683_CR64","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s11481-017-9746-5","volume":"12","author":"V Lawana","year":"2017","unstructured":"Lawana V, Singh N, Sarkar S, Charli A, Jin H, Anantharam V, Kanthasamy AG, Kanthasamy A (2017) Involvement of c-Abl kinase in microglial activation of NLRP3 inflammasome and impairment in autolysosomal system. J Neuroimmune Pharmacol 12(4):624\u2013660. https:\/\/doi.org\/10.1007\/s11481-017-9746-5","journal-title":"J Neuroimmune Pharmacol"},{"issue":"3","key":"2683_CR65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/mds.26488","volume":"31","author":"P Zhang","year":"2016","unstructured":"Zhang P, Shao XY, Qi GJ, Chen Q, Bu LL, Chen LJ, Shi J, Ming J et al (2016) Cdk5-dependent activation of neuronal inflammasomes in Parkinson\u2019s disease. Mov Disord 31(3):366\u2013376. https:\/\/doi.org\/10.1002\/mds.26488","journal-title":"Mov Disord"},{"issue":"1","key":"2683_CR66","doi-asserted-by":"publisher","first-page":"e55375","DOI":"10.1371\/journal.pone.0055375","volume":"8","author":"G Codolo","year":"2013","unstructured":"Codolo G, Plotegher N, Pozzobon T, Brucale M, Tessari I, Bubacco L, de Bernard M (2013) Triggering of inflammasome by aggregated alpha-synuclein, an inflammatory response in synucleinopathies. PLoS ONE 8(1):e55375. https:\/\/doi.org\/10.1371\/journal.pone.0055375","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"2683_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","volume":"202","author":"D Blum-Degen","year":"1995","unstructured":"Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer\u2019s and de novo Parkinson\u2019s disease patients. Neurosci Lett 202(1\u20132):17\u201320. https:\/\/doi.org\/10.1016\/0304-3940(95)12192-7","journal-title":"Neurosci Lett"},{"issue":"11","key":"2683_CR68","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1001\/jamaneurol.2016.2742","volume":"73","author":"XY Qin","year":"2016","unstructured":"Qin XY, Zhang SP, Cao C, Loh YP, Cheng Y (2016) Aberrations in peripheral inflammatory cytokine levels in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol 73(11):1316\u20131324. https:\/\/doi.org\/10.1001\/jamaneurol.2016.2742","journal-title":"JAMA Neurol"},{"issue":"1","key":"2683_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12974-019-1670-6","volume":"17","author":"Z Fan","year":"2020","unstructured":"Fan Z, Pan YT, Zhang ZY, Yang H, Yu SY, Zheng Y, Ma JH, Wang XM (2020) Systemic activation of NLRP3 inflammasome and plasma alpha-synuclein levels are correlated with motor severity and progression in Parkinson\u2019s disease. J Neuroinflammation 17(1):11. https:\/\/doi.org\/10.1186\/s12974-019-1670-6","journal-title":"J Neuroinflammation"},{"issue":"2","key":"2683_CR70","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","volume":"180","author":"M Mogi","year":"1994","unstructured":"Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180(2):147\u2013150. https:\/\/doi.org\/10.1016\/0304-3940(94)90508-8","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"2683_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2014.11.047","volume":"160","author":"Y Yan","year":"2015","unstructured":"Yan Y, Jiang W, Liu L, Wang X, Ding C, Tian Z, Zhou R (2015) Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome. Cell 160(1\u20132):62\u201373. https:\/\/doi.org\/10.1016\/j.cell.2014.11.047","journal-title":"Cell"},{"issue":"1","key":"2683_CR72","doi-asserted-by":"publisher","first-page":"91","DOI":"10.31887\/DCNS.2016.18.1\/pnopoulos","volume":"18","author":"PC Nopoulos","year":"2016","unstructured":"Nopoulos PC (2016) Huntington disease: a single-gene degenerative disorder of the striatum. Dialogues Clin Neurosci 18(1):91\u201398","journal-title":"Dialogues Clin Neurosci"},{"key":"2683_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RA Roos","year":"2010","unstructured":"Roos RA (2010) Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis 5:40. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"2683_CR74","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s0092-8674(00)80513-9","volume":"90","author":"SW Davies","year":"1997","unstructured":"Davies SW, Turmaine M, Cozens BA, DiFiglia M, Sharp AH, Ross CA, Scherzinger E, Wanker EE et al (1997) Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90(3):537\u2013548. https:\/\/doi.org\/10.1016\/s0092-8674(00)80513-9","journal-title":"Cell"},{"issue":"6","key":"2683_CR75","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/107385840100700604","volume":"7","author":"RO Sanchez Mejia","year":"2001","unstructured":"Sanchez Mejia RO, Friedlander RM (2001) Caspases in Huntington\u2019s disease. Neuroscientist 7(6):480\u2013489. https:\/\/doi.org\/10.1177\/107385840100700604","journal-title":"Neuroscientist"},{"issue":"6733","key":"2683_CR76","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/20446","volume":"399","author":"VO Ona","year":"1999","unstructured":"Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS et al (1999) Inhibition of caspase-1 slows disease progression in a mouse model of Huntington\u2019s disease. Nature 399(6733):263\u2013267. https:\/\/doi.org\/10.1038\/20446","journal-title":"Nature"},{"issue":"7","key":"2683_CR77","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/77528","volume":"6","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L et al (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6(7):797\u2013801. https:\/\/doi.org\/10.1038\/77528","journal-title":"Nat Med"},{"issue":"3","key":"2683_CR78","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.clineuro.2004.02.007","volume":"106","author":"A Compston","year":"2004","unstructured":"Compston A (2004) The pathogenesis and basis for treatment in multiple sclerosis. Clin Neurol Neurosurg 106(3):246\u2013248. https:\/\/doi.org\/10.1016\/j.clineuro.2004.02.007","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"2683_CR79","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nri2550","volume":"9","author":"J Goverman","year":"2009","unstructured":"Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9(6):393\u2013407. https:\/\/doi.org\/10.1038\/nri2550","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"2683_CR80","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1189\/jlb.1207844","volume":"84","author":"A Andersson","year":"2008","unstructured":"Andersson A, Covacu R, Sunnemark D, Danilov AI, Dal Bianco A, Khademi M, Wallstrom E, Lobell A et al (2008) Pivotal advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. J Leukoc Biol 84(5):1248\u20131255. https:\/\/doi.org\/10.1189\/jlb.1207844","journal-title":"J Leukoc Biol"},{"issue":"5","key":"2683_CR81","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/brain\/awaa084","volume":"143","author":"S Malhotra","year":"2020","unstructured":"Malhotra S, Costa C, Eixarch H, Keller CW, Amman L, Martinez-Banaclocha H, Midaglia L, Sarro E et al (2020) NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients. Brain 143(5):1414\u20131430. https:\/\/doi.org\/10.1093\/brain\/awaa084","journal-title":"Brain"},{"key":"2683_CR82","doi-asserted-by":"publisher","first-page":"859145","DOI":"10.1155\/2013\/859145","volume":"2013","author":"M Inoue","year":"2013","unstructured":"Inoue M, Shinohara ML (2013) NLRP3 Inflammasome and MS\/EAE. Autoimmune Dis 2013:859145. https:\/\/doi.org\/10.1155\/2013\/859145","journal-title":"Autoimmune Dis"},{"issue":"9","key":"2683_CR83","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1093\/brain\/awx133","volume":"140","author":"MK Mamik","year":"2017","unstructured":"Mamik MK, Power C (2017) Inflammasomes in neurological diseases: emerging pathogenic and therapeutic concepts. Brain 140(9):2273\u20132285. https:\/\/doi.org\/10.1093\/brain\/awx133","journal-title":"Brain"},{"key":"2683_CR84","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jaut.2016.06.015","volume":"73","author":"AE Russi","year":"2016","unstructured":"Russi AE, Walker-Caulfield ME, Guo Y, Lucchinetti CF, Brown MA (2016) Meningeal mast cell-T cell crosstalk regulates T cell encephalitogenicity. J Autoimmun 73:100\u2013110. https:\/\/doi.org\/10.1016\/j.jaut.2016.06.015","journal-title":"J Autoimmun"},{"issue":"1","key":"2683_CR85","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1038\/s41467-018-04376-5","volume":"9","author":"S Voet","year":"2018","unstructured":"Voet S, Mc Guire C, Hagemeyer N, Martens A, Schroeder A, Wieghofer P, Daems C, Staszewski O et al (2018) A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation. Nat Commun 9(1):2036. https:\/\/doi.org\/10.1038\/s41467-018-04376-5","journal-title":"Nat Commun"},{"key":"2683_CR86","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fneur.2018.00135","volume":"9","author":"RW Keane","year":"2018","unstructured":"Keane RW, Dietrich WD, de Rivero Vaccari JP (2018) Inflammasome proteins as biomarkers of multiple sclerosis. Front Neurol 9:135. https:\/\/doi.org\/10.3389\/fneur.2018.00135","journal-title":"Front Neurol"},{"issue":"3","key":"2683_CR87","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Munoz-Planillo R, Inserra MC, Vetter I, Dungan LS et al (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21(3):248\u2013255. https:\/\/doi.org\/10.1038\/nm.3806","journal-title":"Nat Med"},{"issue":"1","key":"2683_CR88","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/ni1415","volume":"8","author":"EM Hur","year":"2007","unstructured":"Hur EM, Youssef S, Haws ME, Zhang SY, Sobel RA, Steinman L (2007) Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8(1):74\u201383. https:\/\/doi.org\/10.1038\/ni1415","journal-title":"Nat Immunol"},{"issue":"4","key":"2683_CR89","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/ana.410350404","volume":"35","author":"SB Prusiner","year":"1994","unstructured":"Prusiner SB, Hsiao KK (1994) Human prion diseases. Ann Neurol 35(4):385\u2013395. https:\/\/doi.org\/10.1002\/ana.410350404","journal-title":"Ann Neurol"},{"issue":"3","key":"2683_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00415-004-0311-9","volume":"251","author":"B Van Everbroeck","year":"2004","unstructured":"Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P (2004) Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol 251(3):298\u2013304. https:\/\/doi.org\/10.1007\/s00415-004-0311-9","journal-title":"J Neurol"},{"issue":"6","key":"2683_CR91","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20151000","volume":"213","author":"C Zhu","year":"2016","unstructured":"Zhu C, Herrmann US, Falsig J, Abakumova I, Nuvolone M, Schwarz P, Frauenknecht K, Rushing EJ et al (2016) A neuroprotective role for microglia in prion diseases. J Exp Med 213(6):1047\u20131059. https:\/\/doi.org\/10.1084\/jem.20151000","journal-title":"J Exp Med"},{"key":"2683_CR92","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1742-2094-9-73","volume":"9","author":"F Shi","year":"2012","unstructured":"Shi F, Yang L, Kouadir M, Yang Y, Wang J, Zhou X, Yin X, Zhao D (2012) The NALP3 inflammasome is involved in neurotoxic prion peptide-induced microglial activation. J Neuroinflammation 9:73. https:\/\/doi.org\/10.1186\/1742-2094-9-73","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2683_CR93","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/BF00369445","volume":"86","author":"A Sasaki","year":"1993","unstructured":"Sasaki A, Hirato J, Nakazato Y (1993) Immunohistochemical study of microglia in the Creutzfeldt-Jakob diseased brain. Acta Neuropathol 86(4):337\u2013344. https:\/\/doi.org\/10.1007\/BF00369445","journal-title":"Acta Neuropathol"},{"issue":"3","key":"2683_CR94","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1750-3639.1998.tb00167.x","volume":"8","author":"A Giese","year":"1998","unstructured":"Giese A, Brown DR, Groschup MH, Feldmann C, Haist I, Kretzschmar HA (1998) Role of microglia in neuronal cell death in prion disease. Brain Pathol 8(3):449\u2013457. https:\/\/doi.org\/10.1111\/j.1750-3639.1998.tb00167.x","journal-title":"Brain Pathol"},{"issue":"24","key":"2683_CR95","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1007\/s00018-012-1140-0","volume":"69","author":"I Hafner-Bratkovic","year":"2012","unstructured":"Hafner-Bratkovic I, Bencina M, Fitzgerald KA, Golenbock D, Jerala R (2012) NLRP3 inflammasome activation in macrophage cell lines by prion protein fibrils as the source of IL-1beta and neuronal toxicity. Cell Mol Life Sci 69(24):4215\u20134228. https:\/\/doi.org\/10.1007\/s00018-012-1140-0","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2683_CR96","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1038\/s41598-018-29720-z","volume":"8","author":"S Srivastava","year":"2018","unstructured":"Srivastava S, Katorcha E, Makarava N, Barrett JP, Loane DJ, Baskakov IV (2018) Inflammatory response of microglia to prions is controlled by sialylation of PrP(Sc). Sci Rep 8(1):11326. https:\/\/doi.org\/10.1038\/s41598-018-29720-z","journal-title":"Sci Rep"},{"issue":"3","key":"2683_CR97","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1007\/s12035-017-0502-x","volume":"55","author":"I Bellezza","year":"2018","unstructured":"Bellezza I, Grottelli S, Costanzi E, Scarpelli P, Pigna E, Morozzi G, Mezzasoma L, Peirce MJ et al (2018) Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Mol Neurobiol 55(3):2350\u20132361. https:\/\/doi.org\/10.1007\/s12035-017-0502-x","journal-title":"Mol Neurobiol"},{"issue":"17","key":"2683_CR98","doi-asserted-by":"publisher","first-page":"8292","DOI":"10.1073\/pnas.91.17.8292","volume":"91","author":"DR Borchelt","year":"1994","unstructured":"Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, Wong PC, Brown RH Jr, Price DL et al (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A 91(17):8292\u20138296. https:\/\/doi.org\/10.1073\/pnas.91.17.8292","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2683_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10753-017-0667-5","volume":"41","author":"A Gugliandolo","year":"2018","unstructured":"Gugliandolo A, Giacoppo S, Bramanti P, Mazzon E (2018) NLRP3 inflammasome activation in a transgenic amyotrophic lateral sclerosis model. Inflammation 41(1):93\u2013103. https:\/\/doi.org\/10.1007\/s10753-017-0667-5","journal-title":"Inflammation"},{"issue":"26","key":"2683_CR100","doi-asserted-by":"publisher","first-page":"15763","DOI":"10.1073\/pnas.95.26.15763","volume":"95","author":"P Pasinelli","year":"1998","unstructured":"Pasinelli P, Borchelt DR, Houseweart MK, Cleveland DW, Brown RH Jr (1998) Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase. Proc Natl Acad Sci U S A 95(26):15763\u201315768. https:\/\/doi.org\/10.1073\/pnas.95.26.15763","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2683_CR101","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/glia.22891","volume":"63","author":"S Johann","year":"2015","unstructured":"Johann S, Heitzer M, Kanagaratnam M, Goswami A, Rizo T, Weis J, Troost D, Beyer C (2015) NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients. Glia 63(12):2260\u20132273. https:\/\/doi.org\/10.1002\/glia.22891","journal-title":"Glia"},{"issue":"29","key":"2683_CR102","doi-asserted-by":"publisher","first-page":"13046","DOI":"10.1073\/pnas.1002396107","volume":"107","author":"F Meissner","year":"2010","unstructured":"Meissner F, Molawi K, Zychlinsky A (2010) Mutant superoxide dismutase 1-induced IL-1beta accelerates ALS pathogenesis. Proc Natl Acad Sci U S A 107(29):13046\u201313050. https:\/\/doi.org\/10.1073\/pnas.1002396107","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2683_CR103","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1111\/nan.12483","volume":"44","author":"S Lehmann","year":"2018","unstructured":"Lehmann S, Esch E, Hartmann P, Goswami A, Nikolin S, Weis J, Beyer C, Johann S (2018) Expression profile of pattern recognition receptors in skeletal muscle of SOD1((G93A)) amyotrophic lateral sclerosis (ALS) mice and sporadic ALS patients. Neuropathol Appl Neurobiol 44(6):606\u2013627. https:\/\/doi.org\/10.1111\/nan.12483","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2683_CR104","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.phrs.2015.11.020","volume":"103","author":"M De Paola","year":"2016","unstructured":"De Paola M, Sestito SE, Mariani A, Memo C, Fanelli R, Freschi M, Bendotti C, Calabrese V et al (2016) Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model. Pharmacol Res 103:180\u2013187. https:\/\/doi.org\/10.1016\/j.phrs.2015.11.020","journal-title":"Pharmacol Res"},{"issue":"40","key":"2683_CR105","doi-asserted-by":"publisher","first-page":"15558","DOI":"10.1073\/pnas.0807419105","volume":"105","author":"DR Beers","year":"2008","unstructured":"Beers DR, Henkel JS, Zhao W, Wang J, Appel SH (2008) CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS. Proc Natl Acad Sci U S A 105(40):15558\u201315563. https:\/\/doi.org\/10.1073\/pnas.0807419105","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2683_CR106","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11481-009-9171-5","volume":"4","author":"JS Henkel","year":"2009","unstructured":"Henkel JS, Beers DR, Zhao W, Appel SH (2009) Microglia in ALS: the good, the bad, and the resting. J Neuroimmune Pharmacol 4(4):389\u2013398. https:\/\/doi.org\/10.1007\/s11481-009-9171-5","journal-title":"J Neuroimmune Pharmacol"},{"issue":"1","key":"2683_CR107","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1002\/ana.410280106","volume":"28","author":"JD Rothstein","year":"1990","unstructured":"Rothstein JD, Tsai G, Kuncl RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL et al (1990) Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 28(1):18\u201325. https:\/\/doi.org\/10.1002\/ana.410280106","journal-title":"Ann Neurol"},{"key":"2683_CR108","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1742-2094-10-106","volume":"10","author":"R Zhang","year":"2013","unstructured":"Zhang R, Liu Y, Yan K, Chen L, Chen XR, Li P, Chen FF, Jiang XD (2013) Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury. J Neuroinflammation 10:106. https:\/\/doi.org\/10.1186\/1742-2094-10-106","journal-title":"J Neuroinflammation"},{"issue":"12","key":"2683_CR109","doi-asserted-by":"publisher","first-page":"e0210128","DOI":"10.1371\/journal.pone.0210128","volume":"13","author":"N Kerr","year":"2018","unstructured":"Kerr N, Lee SW, Perez-Barcena J, Crespi C, Ibanez J, Bullock MR, Dietrich WD, Keane RW et al (2018) Inflammasome proteins as biomarkers of traumatic brain injury. PLoS ONE 13(12):e0210128. https:\/\/doi.org\/10.1371\/journal.pone.0210128","journal-title":"PLoS ONE"},{"key":"2683_CR110","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3389\/fphar.2017.00459","volume":"8","author":"N Irrera","year":"2017","unstructured":"Irrera N, Pizzino G, Calo M, Pallio G, Mannino F, Fama F, Arcoraci V, Fodale V et al (2017) Lack of the Nlrp3 inflammasome improves mice recovery following traumatic brain injury. Front Pharmacol 8:459. https:\/\/doi.org\/10.3389\/fphar.2017.00459","journal-title":"Front Pharmacol"},{"key":"2683_CR111","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fphar.2012.00060","volume":"3","author":"JT Weber","year":"2012","unstructured":"Weber JT (2012) Altered calcium signaling following traumatic brain injury. Front Pharmacol 3:60. https:\/\/doi.org\/10.3389\/fphar.2012.00060","journal-title":"Front Pharmacol"},{"issue":"1","key":"2683_CR112","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0304-3940(03)00497-x","volume":"345","author":"D Awasthi","year":"2003","unstructured":"Awasthi D, Kutz SC, Beuerman R, Nguyen D, Carey ME, Zeiller S (2003) Early gene expression in the rat cortex after experimental traumatic brain injury and hypotension. Neurosci Lett 345(1):29\u201332. https:\/\/doi.org\/10.1016\/s0304-3940(03)00497-x","journal-title":"Neurosci Lett"},{"issue":"3","key":"2683_CR113","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1460-9568.2009.06820.x","volume":"30","author":"F Clausen","year":"2009","unstructured":"Clausen F, Hanell A, Bjork M, Hillered L, Mir AK, Gram H, Marklund N (2009) Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur J Neurosci 30(3):385\u2013396. https:\/\/doi.org\/10.1111\/j.1460-9568.2009.06820.x","journal-title":"Eur J Neurosci"},{"issue":"6","key":"2683_CR114","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.3171\/2012.9.JNS12815","volume":"117","author":"S Adamczak","year":"2012","unstructured":"Adamczak S, Dale G, de Rivero Vaccari JP, Bullock MR, Dietrich WD, Keane RW (2012) Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. J Neurosurg 117(6):1119\u20131125. https:\/\/doi.org\/10.3171\/2012.9.JNS12815","journal-title":"J Neurosurg"},{"issue":"1","key":"2683_CR115","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12028-017-0378-7","volume":"27","author":"JS Wallisch","year":"2017","unstructured":"Wallisch JS, Simon DW, Bayir H, Bell MJ, Kochanek PM, Clark RSB (2017) Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children. Neurocrit Care 27(1):44\u201350. https:\/\/doi.org\/10.1007\/s12028-017-0378-7","journal-title":"Neurocrit Care"},{"key":"2683_CR116","doi-asserted-by":"publisher","unstructured":"Piancone F, La Rosa F, Marventano I, Saresella M, Clerici M (2021) The role of the inflammasome in neurodegenerative diseases. Molecules 26(4):953. https:\/\/doi.org\/10.3390\/molecules26040953","DOI":"10.3390\/molecules26040953"},{"issue":"7","key":"2683_CR117","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4103\/1673-5374.272576","volume":"15","author":"Y Duan","year":"2020","unstructured":"Duan Y, Kelley N, He Y (2020) Role of the NLRP3 inflammasome in neurodegenerative diseases and therapeutic implications. Neural Regen Res 15(7):1249\u20131250. https:\/\/doi.org\/10.4103\/1673-5374.272576","journal-title":"Neural Regen Res"},{"issue":"3","key":"2683_CR118","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D\u2019Agostino D, Planavsky N et al (2015) The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21(3):263\u2013269. https:\/\/doi.org\/10.1038\/nm.3804","journal-title":"Nat Med"},{"issue":"13","key":"2683_CR119","doi-asserted-by":"publisher","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","volume":"285","author":"C Juliana","year":"2010","unstructured":"Juliana C, Fernandes-Alnemri T, Wu J, Datta P, Solorzano L, Yu JW, Meng R, Quong AA et al (2010) Anti-inflammatory compounds parthenolide and Bay 11\u20137082 are direct inhibitors of the inflammasome. J Biol Chem 285(13):9792\u20139802. https:\/\/doi.org\/10.1074\/jbc.M109.082305","journal-title":"J Biol Chem"},{"issue":"4","key":"2683_CR120","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.imbio.2013.11.003","volume":"219","author":"H Ahn","year":"2014","unstructured":"Ahn H, Kim J, Jeung EB, Lee GS (2014) Dimethyl sulfoxide inhibits NLRP3 inflammasome activation. Immunobiology 219(4):315\u2013322. https:\/\/doi.org\/10.1016\/j.imbio.2013.11.003","journal-title":"Immunobiology"},{"issue":"225","key":"2683_CR121","doi-asserted-by":"publisher","first-page":"ra38","DOI":"10.1126\/scisignal.2002767","volume":"5","author":"M Inoue","year":"2012","unstructured":"Inoue M, Williams KL, Oliver T, Vandenabeele P, Rajan JV, Miao EA, Shinohara ML (2012) Interferon-beta therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome. Sci Signal 5(225):ra38. https:\/\/doi.org\/10.1126\/scisignal.2002767","journal-title":"Sci Signal"},{"key":"2683_CR122","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.bbagen.2014.07.012","volume":"10","author":"E Isakov","year":"1840","unstructured":"Isakov E, Weisman-Shomer P (1840) Benhar M (2014) Suppression of the pro-inflammatory NLRP3\/interleukin-1beta pathway in macrophages by the thioredoxin reductase inhibitor auranofin. Biochim Biophys Acta 10:3153\u20133161. https:\/\/doi.org\/10.1016\/j.bbagen.2014.07.012","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2683_CR123","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1189\/jlb.3A0114-005RR","volume":"96","author":"H Honda","year":"2014","unstructured":"Honda H, Nagai Y, Matsunaga T, Okamoto N, Watanabe Y, Tsuneyama K, Hayashi H, Fujii I et al (2014) Isoliquiritigenin is a potent inhibitor of NLRP3 inflammasome activation and diet-induced adipose tissue inflammation. J Leukoc Biol 96(6):1087\u20131100. https:\/\/doi.org\/10.1189\/jlb.3A0114-005RR","journal-title":"J Leukoc Biol"},{"issue":"2","key":"2683_CR124","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","volume":"289","author":"Y He","year":"2014","unstructured":"He Y, Varadarajan S, Munoz-Planillo R, Burberry A, Nakamura Y, Nunez G (2014) 3,4-methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. J Biol Chem 289(2):1142\u20131150. https:\/\/doi.org\/10.1074\/jbc.M113.515080","journal-title":"J Biol Chem"},{"issue":"6","key":"2683_CR125","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.4049\/jimmunol.1401611","volume":"194","author":"NK Maier","year":"2015","unstructured":"Maier NK, Leppla SH, Moayeri M (2015) The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes. J Immunol 194(6):2776\u20132785. https:\/\/doi.org\/10.4049\/jimmunol.1401611","journal-title":"J Immunol"},{"issue":"6197","key":"2683_CR126","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.1254790","volume":"345","author":"A Reboldi","year":"2014","unstructured":"Reboldi A, Dang EV, McDonald JG, Liang G, Russell DW, Cyster JG (2014) Inflammation. 25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon. Science 345(6197):679\u2013684. https:\/\/doi.org\/10.1126\/science.1254790","journal-title":"Science"},{"key":"2683_CR127","doi-asserted-by":"publisher","unstructured":"Gordon R, Albornoz EA, Christie DC, Langley MR, Kumar V, Mantovani S, Robertson AAB, Butler MS, Rowe DB, O'Neill LA, Kanthasamy AG, Schroder K, Cooper MA, Woodruff TM (2018) Inflammasome inhibition prevents alpha-synuclein pathology and dopaminergic neurodegeneration in mice. Sci Transl Med 10(465):eaah4066. https:\/\/doi.org\/10.1126\/scitranslmed.aah4066","DOI":"10.1126\/scitranslmed.aah4066"},{"key":"2683_CR128","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","volume":"61","author":"C Dempsey","year":"2017","unstructured":"Dempsey C, Rubio Araiz A, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O\u2019Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP\/PS1 mice. Brain Behav Immun 61:306\u2013316. https:\/\/doi.org\/10.1016\/j.bbi.2016.12.014","journal-title":"Brain Behav Immun"},{"issue":"2","key":"2683_CR129","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3233\/JAD-181259","volume":"72","author":"F La Rosa","year":"2019","unstructured":"La Rosa F, Saresella M, Marventano I, Piancone F, Ripamonti E, Al-Daghri N, Bazzini C, Zoia CP, Conti E, Ferrarese C, Clerici M (2019) Stavudine reduces NLRP3 inflammasome activation and modulates amyloid-beta autophagy. J Alzheimers Dis 72(2):401\u2013412. https:\/\/doi.org\/10.3233\/JAD-181259","journal-title":"J Alzheimers Dis"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02683-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02683-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T11:48:29Z","timestamp":1650368909000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02683-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,23]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["2683"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02683-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,23]]},"assertion":[{"value":"30 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All contributing authors agree to the publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}